Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Background/Aims: Aspirin has been demonstrated to possess potent chemopreventive and anticancer effects on prostate cancer. However, the more detailed molecular mechanisms of aspirin to suppress prostate cancer cell invasion have not been clearly elucidated. Methods: Transwell assays were performed...

Description complète

Détails bibliographiques
Auteurs principaux: Chongjun Shi, Nini Zhang, Yang Feng, Jiewei Cao, Xuyi Chen, Bin Liu
Format: Article
Langue:English
Publié: Cell Physiol Biochem Press GmbH & Co KG 2017-03-01
Collection:Cellular Physiology and Biochemistry
Sujets:
Invasion
Matrix metalloproteinase
Nuclear factor-kappa B
Prostate cancer
Urokinase-type plasminogen activator
Accès en ligne:http://www.karger.com/Article/FullText/464434

Documents similaires

Documents similaires